Cite

HARVARD Citation

    Alexander, B. et al. (n.d.). 998. Clinical Outcomes and Cost Savings of Dalbavancin Use in OPAT: Focus on Complicated Staphylococcus aureus Infections. Open forum infectious diseases. p. . [Online]. 
  
Back to record